Adamis Pharmaceuticals Corporation (NASDAQ:ADMP)

Adamis Pharmaceuticals Corporation (NASDAQ:ADMP)

Share Price
$ 1.30
0.035 (2.78 %)
Market Cap
$61.44 m
Proactive Investors - Run By Investors For Investors

Adamis Pharmaceuticals Corporation

Adamis Pharmaceuticals Corporation is a specialty biopharmaceutical company primarily focused on developing and commercializing products in various therapeutic areas, including respiratory disease and allergy. The company’s Symjepi (epinephrine) Injection 0.3mg and Symjepi (epinephrine) Injection 0.15 mg products were approved for use in the emergency treatment of acute allergic reactions,...

52-week High/Low: $5.10 / $1.26
Sector: MSN - Healthcare & pharmaceuticals
Market Cap: $61.44 m
col 3
col 4
col 5
col 6

Adamis Pharmaceuticals Corporation Timeline

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use